Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EWSR1 pseudogene 2 (EWSR1P2) is a non-functional genomic sequence related to the EWSR1 gene. Unlike EWSR1, which encodes a multifunctional RNA binding protein involved in transcriptional regulation, RNA splicing, and is a fusion partner in various cancers[1][4][2][5], EWSR1P2 does not encode a protein, is not expressed, and does not play a direct biological or therapeutic role. There are several EWSR1-related pseudogenes on different chromosomes[4]. Current evidence suggests EWSR1P2 has no role in disease, therapy, or biomarker development. This distinguishes it sharply from EWSR1, which is a frequent fusion gene in soft tissue and bone cancers such as Ewing sarcoma[1][2][4]. Key distinctions: - EWSR1P2 is a pseudogene: does not produce functional protein and is not considered a therapeutic target[4]. - EWSR1 is clinically significant: involved in tumorigenesis and studied in cancer[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EWSR1 pseudogene 2 (EWSR1P2).